Search Results - "Usui, Soichiro"

Refine Results
  1. 1

    Clinical Diagnostic Criteria of Familial Hypercholesterolemia ― A Comparison of the Japan Atherosclerosis Society and Dutch Lipid Clinic Network Criteria by Tada, Hayato, Okada, Hirofumi, Nomura, Akihiro, Usui, Soichiro, Sakata, Kenji, Nohara, Atsushi, Yamagishi, Masakazu, Takamura, Masayuki, Kawashiri, Masa-aki

    Published in Circulation Journal (25-05-2021)
    “…Background:This study is aimed to compare the efficacy of the 2017 Japan Atherosclerosis Society (JAS) familial hypercholesterolemia (FH) criteria, which…”
    Get full text
    Journal Article
  2. 2

    Challenges of Precision Medicine for Atherosclerotic Cardiovascular Disease Based on Human Genome Information by Tada, Hayato, Usui, Soichiro, Sakata, Kenji, Takamura, Masayuki, Kawashiri, Masa-aki

    Published in Journal of Atherosclerosis and Thrombosis (01-04-2021)
    “…Precision or personalized medicine is currently gaining a lot of attention. Clinical evidence for its effectiveness has been established based on randomized…”
    Get full text
    Journal Article
  3. 3

    Comparison of Human Selenoprotein P Determinants in Serum between Our Original Methods and Commercially Available Kits by Saito, Yoshiro, Misu, Hirofumi, Takayama, Hiroaki, Takashima, Shin-ichiro, Usui, Soichiro, Takamura, Masayuki, Kaneko, Shuichi, Takamura, Toshinari, Noguchi, Noriko

    Published in Biological & pharmaceutical bulletin (01-05-2018)
    “…Selenoprotein P (SeP) is a selenium (Se)-rich extracellular protein. SeP is identified as a hepatokine, causing insulin resistance in type 2 diabetes. Thus,…”
    Get full text
    Journal Article
  4. 4

    Validation of the 2022 Clinical Diagnostic Criteria of Familial Hypercholesterolemia in Japan by Tada, Hayato, Nohara, Atsushi, Usui, Soichiro, Sakata, Kenji, Kawashiri, Masa-aki, Takamura, Masayuki

    Published in Journal of Atherosclerosis and Thrombosis (01-05-2024)
    “…Aim: In 2022, the Japan Atherosclerosis Society (JAS) has revised its clinical diagnostic criteria of familial hypercholesterolemia (FH) and adopted the use of…”
    Get full text
    Journal Article
  5. 5

    Low-Density Lipoprotein Cholesterol Level cannot be too Low: Considerations from Clinical Trials, Human Genetics, and Biology by Tada, Hayato, Usui, Soichiro, Sakata, Kenji, Takamura, Masayuki, Kawashiri, Masa-aki

    Published in Journal of Atherosclerosis and Thrombosis (01-06-2020)
    “…LDL cholesterol is by far the best established “causal” cardiovascular risk. It is distributed normally, and the mean value ranges around 100~120 mg/dl. In…”
    Get full text
    Journal Article
  6. 6

    Healthy lifestyle, lipoprotein (a) levels and the risk of coronary artery disease by Tada, Hayato, Yamagami, Kan, Sakata, Kenji, Usui, Soichiro, Kawashiri, Masa‐aki, Takamura, Masayuki

    Published in European journal of clinical investigation (01-01-2024)
    “…Background Lipoprotein (a) [Lp(a)] is associated with coronary artery disease (CAD). However, the role of healthy lifestyle against the risk of CAD with…”
    Get full text
    Journal Article
  7. 7

    Impact of the severe familial hypercholesterolemia status on atherosclerotic risks by Tada, Hayato, Nohara, Atsushi, Usui, Soichiro, Sakata, Kenji, Kawashiri, Masa-aki, Takamura, Masayuki

    Published in Scientific reports (13-11-2023)
    “…Risks of atherosclerotic events substantially vary even among patients with familial hypercholesterolemia (FH) with extremely high risk based on life-long…”
    Get full text
    Journal Article
  8. 8

    Optimal lesion size index to prevent conduction gap during pulmonary vein isolation by Kanamori, Naomi, Kato, Takeshi, Sakagami, Satoru, Saeki, Takahiro, Kato, Chieko, Kawai, Keiichi, Chikata, Akio, Takashima, Shin‐ichiro, Murai, Hisayoshi, Usui, Soichiro, Furusho, Hiroshi, Kaneko, Shuichi, Takamura, Masayuki

    “…Introduction A novel real‐time lesion size index (LSI) that incorporates contact force (CF), time, and power has been developed for safe and effective catheter…”
    Get full text
    Journal Article
  9. 9

    The Assessment of Carotid Atherosclerotic Plaque among Young Patients with Familial Hypercholesterolemia by Shibayama, Junichi, Tada, Hayato, Sakata, Kenji, Usui, Soichiro, Takamura, Masayuki, Kawashiri, Masa-aki

    Published in Internal Medicine (01-11-2022)
    “…Objective Few data exist regarding when atherosclerotic changes occur among patients with familial hypercholesterolemia (FH). Carotid ultrasonography is a…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Treatment with a Direct Oral Anticoagulant for Nonbacterial Thrombotic Endocarditis by Tamura, Yudai, Sakata, Kenji, Terada, Kazushi, Usui, Soichiro, Kawashiri, Masa-aki, Takamura, Masayuki

    Published in Internal Medicine (15-06-2021)
    “…We herein report a case of nonbacterial thrombotic endocarditis (NBTE) in a patient with previously undiagnosed lung cancer. A 62-year-old woman presented to…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    Attainment of the low-density lipoprotein cholesterol treatment target and prognosis of heterozygous familial hypercholesterolemia by Tada, Hayato, Nomura, Akihiro, Nohara, Atsushi, Usui, Soichiro, Sakata, Kenji, Hayashi, Kenshi, Fujino, Noboru, Takamura, Masayuki, Kawashiri, Masa-aki

    Published in Atherosclerosis (01-04-2023)
    “…No previous study has investigated the association between attainment of low-density lipoprotein (LDL) cholesterol treatment target and better prognosis in…”
    Get full text
    Journal Article
  17. 17

    Autophagy plays an essential role in mediating regression of hypertrophy during unloading of the heart by Hariharan, Nirmala, Ikeda, Yoshiyuki, Hong, Chull, Alcendor, Ralph R, Usui, Soichiro, Gao, Shumin, Maejima, Yasuhiro, Sadoshima, Junichi

    Published in PloS one (07-01-2013)
    “…Autophagy is a bulk degradation mechanism for cytosolic proteins and organelles. The heart undergoes hypertrophy in response to mechanical load but hypertrophy…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Important Role of Endogenous Nerve Growth Factor Receptor in the Pathogenesis of Hypoxia-Induced Pulmonary Hypertension in Mice by Goten, Chiaki, Usui, Soichiro, Takashima, Shin-Ichiro, Inoue, Oto, Yamaguchi, Kosei, Hashimuko, Daiki, Takeda, Yusuke, Nomura, Ayano, Sakata, Kenji, Kaneko, Shuichi, Takamura, Masayuki

    “…Pulmonary arterial hypertension (PAH) remains a disease with poor prognosis; thus, a new mechanism for PAH treatment is necessary. Circulating nerve growth…”
    Get full text
    Journal Article
  20. 20

    Inhibition of Endogenous Mst1 Prevents Apoptosis and Cardiac Dysfunction Without Affecting Cardiac Hypertrophy After Myocardial Infarction by Odashima, Mari, Usui, Soichiro, Takagi, Hiromitsu, Hong, Chull, Liu, Jing, Yokota, Mitsuhiro, Sadoshima, Junichi

    Published in Circulation research (11-05-2007)
    “…Mammalian sterile 20–like kinase-1 (Mst1) plays an important role in mediating cardiac myocyte apoptosis in response to ischemia/reperfusion. Whether or not…”
    Get full text
    Journal Article